GlaxoSmithKline Consumer Healthcare`s (GLAXOCON) principal activities include manufacture and distribution of a wide range of healthcare foods, drugs, pharmaceuticals and dairy products. The products include malted milk food, malted foods, biscuits, energy and protein foods, milk powders, ghee, milk fluid and milk cream. The group exports to Bangladesh, Myanmar, Sri Lanka, Middle East, Nepal and other markets. It was incorporated in 1958 as a 40% subsidiary of Smithkline Beecham Plc of UK. The manufacturing plants of GLAXOCON are located in Nabha (Punjab), Rajahmundry (Andhra Pradesh) and Sonepat (Haryana).
The company has a 100-year-old brand like Horlicks in its portfolio. The company also manufactures and markets Boost, Viva, Maltova, biscuits (under Horlicks brand). Apart from that, the company also sells its products like Horlicks and Boost through vending machines. GLAXOCON also has presence in over-the-counter drugs like Crocin, Eno and Iodex. The Sonepat factory of GLAXOCON has a capacity to produce 26,100 tons of Horlicks per annum and is automated in such a way that the final product comes out hygienically without being touched by human hands. The Gurgaon-based R&D center of GLAXOCON has been fully functional. The company plans to leverage its expertise in the food processing industry to innovate and serve the domestic consumers who are becoming more and more health conscious. GLAXOCON wants to improve its out-of-home business by boosting its vending business.
Update
GlaxoSmithkline Consumer Healthcare has posted a net profit of Rs. 1030.30 million for the quarter ended September 30, 2011 as compared to Rs. 785.70 million for the quarter ended September 30, 2010. Total Income has increased from Rs. 6459.80 million for the quarter ended September 30, 2010 to Rs. 7677.10 million for the quarter ended September 30, 2011.
You
should Trade Less But Trade Accurately & this is Achieved with our Tip.
